Intravitreal long-term sustained ranibizumab delivery using injectable microgel-embedded hydrogel
Retinal vascular disease is the leading cause of visual impairment. Although intravitreal drug injections are the most suitable approach for addressing retinal disorders, existing clinical treatments necessitate repeated administration, imposing a substantial burden on patients with various intraocu...
Saved in:
Main Authors: | Simin Lee (Author), Jun Young Park (Author), Hye Kyoung Hong (Author), Joo Young Son (Author), Byungwook Kim (Author), Jae Yong Chung (Author), Se Joon Woo (Author), Ki Dong Park (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Severe hypotony and filtering bleb leak after intravitreal injection of ranibizumab
by: Ilias Georgalas, et al.
Published: (2008) -
Evaluation of intravitreal ranibizumab injection as a line of treatment for chronic central serous retinopathy
by: Emad A.A Saliem
Published: (2019) -
Clinical effects and safety of treating diabetic macular edema with intravitreal injection of ranibizumab combined with retinal photocoagulation
by: Yan PS, et al.
Published: (2016) -
Intravitreal corticosteroid implant vs intravitreal ranibizumab for the treatment of macular edema: a meta-analysis of randomized controlled trials
by: Wei Q, et al.
Published: (2019) -
Cytokine and Chemokine Profile Changes in Patients with Neovascular Age-Related Macular Degeneration After Intravitreal Ranibizumab Injection for Choroidal Neovascularization
by: Sun T, et al.
Published: (2021)